Literature DB >> 11141315

Comprehensive human NAT2 genotype method using single nucleotide polymorphism-specific polymerase chain reaction primers and fluorogenic probes.

M A Doll1, D W Hein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11141315     DOI： 10.1006/abio.2000.4892

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  27 in total

1.  Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.

Authors:  Lisa F Potts; Alex C Cambon; Owen A Ross; Rosa Rademakers; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Shesh N Rai; Matthew J Farrer; David W Hein; Irene Litvan
Journal:  BMC Med Genet       Date:  2012-03-17       Impact factor: 2.103

2.  Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.

Authors:  Mark A Doll; Yu Zang; Timothy Moeller; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2010-04-29       Impact factor: 4.030

3.  Role of the N-acetylation polymorphism in solithromycin metabolism.

Authors:  David W Hein; Mark A Doll
Journal:  Pharmacogenomics       Date:  2017-04-24       Impact factor: 2.533

4.  Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.

Authors:  Sangita Sharma; Xia Cao; Lynne R Wilkens; Jennifer Yamamoto; Annette Lum-Jones; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

5.  Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation.

Authors:  Christopher Vinnard; Shruthi Ravimohan; Neo Tamuhla; Vijay Ivaturi; Jotam Pasipanodya; Shashikant Srivastava; Chawangwa Modongo; Nicola M Zetola; Drew Weissman; Tawanda Gumbo; Gregory P Bisson
Journal:  Br J Clin Pharmacol       Date:  2016-12-09       Impact factor: 4.335

6.  A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.

Authors:  Montserrat García-Closas; David W Hein; Debra Silverman; Núria Malats; Meredith Yeager; Kevin Jacobs; Mark A Doll; Jonine D Figueroa; Dalsu Baris; Molly Schwenn; Manolis Kogevinas; Alison Johnson; Nilanjan Chatterjee; Lee E Moore; Timothy Moeller; Francisco X Real; Stephen Chanock; Nathaniel Rothman
Journal:  Pharmacogenet Genomics       Date:  2011-04       Impact factor: 2.089

7.  Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.

Authors:  Mark A Doll; David W Hein
Journal:  Arch Toxicol       Date:  2017-05-17       Impact factor: 5.153

8.  Variability in drug metabolizing enzyme activity in HIV-infected patients.

Authors:  Amanda E Jones; Kevin C Brown; Rebecca E Werner; Karl Gotzkowsky; Andrea Gaedigk; Mike Blake; David W Hein; Charles van der Horst; Angela D M Kashuba
Journal:  Eur J Clin Pharmacol       Date:  2010-01-19       Impact factor: 2.953

9.  N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.

Authors:  Kathy B Baumgartner; Thomas J Schlierf; Dongyan Yang; Mark A Doll; David W Hein
Journal:  Toxicol Sci       Date:  2009-08-19       Impact factor: 4.849

10.  Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.

Authors:  Li Jiao; Mark A Doll; David W Hein; Melissa L Bondy; Manal M Hassan; James E Hixson; James L Abbruzzese; Donghui Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.